# Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation

Study · id `cardio:ct-nct05556460` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05556460](<https://clinicaltrials.gov/study/NCT05556460>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05556460

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 236 participants.

## Technical summary

Registry record NCT05556460. Randomized; single masking; primary purpose treatment. Start 2024-09-03 (actual); primary completion 2028-08-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 236 participants (planned count; ClinicalTrials.gov record NCT05556460, source copy `cardio:ctgov-nct05556460-2026-06-12`, retrieved 2026-10-26)
- Started: 2024-09-03 (actual) (ClinicalTrials.gov record NCT05556460, source copy `cardio:ctgov-nct05556460-2026-06-12`, retrieved 2026-10-26)
- Primary completion: 2028-08-15 (anticipated) (ClinicalTrials.gov record NCT05556460, source copy `cardio:ctgov-nct05556460-2026-06-12`, retrieved 2026-10-26)
- Completion: 2032-08-15 (anticipated) (ClinicalTrials.gov record NCT05556460, source copy `cardio:ctgov-nct05556460-2026-06-12`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05556460, source copy `cardio:ctgov-nct05556460-2026-06-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05556460-2026-06-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation
- Condition: Tricuspid Regurgitation
- Intervention (Device): DragonFly-T Transcatheter Tricuspid Valve Repair System
- Intervention (Drug): Medical therapy
- Lead sponsor: Hangzhou Valgen Medtech Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Tricuspid regurgitation (`cardio:tricuspid-regurgitation`)
- Registry lists this organization as the lead sponsor: Hangzhou Valgen Medtech Co., Ltd (`cardio:org-hangzhou-valgen-medtech-co-ltd`)

## Provenance

Content hash: 5118b18c339bc0e25d1f518dafba36dbe89df48c639b89525ef8d59856a6bff0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
